Zhejiang Wolwo Shares Reach Upper Limit On Opening Day Of IPO
This article was originally published in PharmAsia News
Executive Summary
Zhejiang Wolwo Bio-Pharmaceutical's initial public offering was so successful, trading had to be suspended twice as speculators drove the share prices 44% above the opening IPO offer, the legal limit.